HolderBook

FREELINE THERAPEUTICS HLDGS (FRLN)

Institutional ownership reported to the SEC as of Q4 2023, across 14 quarters.

15
Reporting holders
$13.1M
Reported value
0.0%
Calls
0.0%
Puts
+4
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
Syncona Portfolio Ltd$9.3M1,466,5075.91%9qHELD
JPMORGAN CHASE & CO$852.9K134,1060.00%newNEW
UBS Group AG$632.9K99,3580.00%3q+190.5%+$415.0K
Blue Owl Capital Holdings LP$552.0K86,6540.13%newNEW
MORGAN STANLEY$544.7K85,5140.00%3q+101.5%+$274.4K
PenderFund Capital Management Ltd.$509.0K60,4010.17%newNEW
RENAISSANCE TECHNOLOGIES LLC$220.0K34,4600.00%3q+30.7%+$51.7K
HARBOR CAPITAL ADVISORS, INC.$129.4K20,3520.02%3q+62.8%+$49.9K
SPHERA FUNDS MANAGEMENT LTD.$104.8K16,4450.02%newNEW
NORTHERN TRUST CORP$99.7K15,6590.00%3qHELD
49 WEALTH MANAGEMENT, LLC$98.9K15,5190.03%newFIRST
RHUMBLINE ADVISERS$9851550.00%2q+34.8%
Gradient Investments LLC$6371000.00%newNEW
Aspire Private Capital, LLC$509800.00%3qHELD
Qube Research & Technologies Ltd$2540.00%2qHELD

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q4 202315$13.1M2,035,3145500.0%
Q3 202311$3.7M855,2233500.0%
Q2 202310$1.3M506,63210000.0%
Q1 202314$6.8M14,856,8691360.0%
Q4 202215$7.7M16,060,1754130.0%
Q3 202213$26.4M37,948,2851250.0%
Q2 202216$33.2M37,990,8661540.0%
Q1 202218$21.3M35,892,23751110.0%
Q4 202118$26.0M13,200,5100750.0%
Q3 202120$36.1M10,611,1629530.0%
Q2 202116$96.2M11,859,2331360.0%
Q1 202119$144.0M11,770,3090250.0%
Q4 202020$216.6M11,923,6782670.0%
Q3 202022$154.8M9,975,30922000.0%